Janus Henderson Investors US’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | $189M | Buy |
4,359,384
+2,002,899
| +85% | +$86.7M | 0.15% | 188 |
|
|
2016
Q4 | $91.2M | Buy |
2,356,485
+224,906
| +11% | +$8.7M | 0.08% | 318 |
|
|
2016
Q3 | $108M | Sell |
2,131,579
-34,994
| -2% | -$1.77M | 0.09% | 283 |
|
|
2016
Q2 | $98.5M | Sell |
2,166,573
-65,012
| -3% | -$2.95M | 0.08% | 291 |
|
|
2016
Q1 | $88.3M | Buy |
2,231,585
+276,677
| +14% | +$10.9M | 0.08% | 309 |
|
|
2015
Q4 | $111M | Buy |
1,954,908
+392,259
| +25% | +$22.2M | 0.09% | 266 |
|
|
2015
Q3 | $62.2M | Sell |
1,562,649
-179,780
| -10% | -$7.15M | 0.06% | 371 |
|
|
2015
Q2 | $83.2M | Buy |
1,742,429
+397,828
| +30% | +$19M | 0.07% | 339 |
|
|
2015
Q1 | $53.4M | Buy |
1,344,601
+68,237
| +5% | +$2.71M | 0.04% | 439 |
|
|
2014
Q4 | $28.5M | Buy |
1,276,364
+277,209
| +28% | +$6.19M | 0.02% | 545 |
|
|
2014
Q3 | $15.7M | Buy |
999,155
+277,667
| +38% | +$4.35M | 0.01% | 619 |
|
|
2014
Q2 | $10.7M | Buy |
721,488
+47,824
| +7% | +$710K | 0.01% | 664 |
|
|
2014
Q1 | $10.8M | Sell |
673,664
-44,638
| -6% | -$719K | 0.01% | 657 |
|
|
2013
Q4 | $6.71M | Sell |
718,302
-283,657
| -28% | -$2.65M | 0.01% | 725 |
|
|
2013
Q3 | $11.3M | Buy |
+1,001,959
| New | +$11.3M | 0.01% | 625 |
|